Searchable abstracts of presentations at key conferences in endocrinology

ea0094p343 | Metabolism, Obesity and Diabetes | SFEBES2023

Familial hypercholesterolaemia patients in a lipid clinic: Characteristics and outcomes

Htut Zin , Baynes Kevin

Objective: The NHS long term plan aims to identify 25% of the Familial Hypercholesterolaemia (FH) patients in England by 2025. This study aimed to identify patients with FH, assess their classification according to the Dutch Lipid Clinic Network (DLCN) criteria, and evaluate treatment outcomes.Methods: We conducted a retrospective analysis of patients referred for assessment of possible FH who went on to have genetic tes...

ea0018p34 | (1) | MES2008

A potential complication of radiotherapy for acromegaly

Lecamwasam Varunika , Abbara Ali , Bell Richard , Baynes Kevin , Rafique Akkib

Case report: A 40-year-old lady was diagnosed with acromegaly in 1993 after presentation with clinical symptoms. Imaging showed a 1 cm pituitary lesion and she underwent transphenoidal hypophysectomy in 1993. Post-operatively she was rendered hypopituitary, but still had biochemical evidence of active acromegaly. She proceeded to external beam radiotherapy and was started on bromocriptine medical therapy.On routine review in 2006, her acromegaly was bioc...

ea0018p32 | (1) | MES2008

Primary hyperparathyroidism presenting in pregnancy

Abbara Ali , Lecamwasam Varunika , Baynes Kevin , Bell Richard , Kurzawinski Thomas , Neila Mahadevan , Rafique Akkib , Kubba Faris

A 25-year-old pregnant lady presented to the accident and emergency department at 16 weeks gestation with intractable vomiting, weight loss and lethargy. She reported a 2 months history of hyperemesis gravidarum managed in the community prior to admission.She had no past medical history and her only medication was of a Polish antenatal vitamin containing 400 IU of Vitamin D (D2). Her blood biochemistry revealed a markedly raised corrected calcium at 3.57...

ea0031p187 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2013

Acute effects of co-infusion of peptide YY (3–36) and glucagon-like peptide-1 on insulin secretion and insulin sensitivity

Tan Tricia , Salem Victoria , Troke Rachel , De Silva Akila , Alsafi Ali , Misra Shivani , Baynes Kevin , Ghatei Mohammed , Minnion James , Field Ben , Godsland Ian , Bloom Stephen R

The amelioration of type 2 diabetes and sustained weight loss after bariatric surgery are thought to be due to elevated circulating levels of the gut hormones peptide YY3–36 (PYY3–36) and glucagon-like peptide-1 (GLP-1). GLP-1 augments the insulin response to an oral glucose load. PYY3–36 has appetite-inhibitory effects and contributes to longer-term weight loss. Rodent studies provide conflicting data regarding the effects of PY...